News
Former club captain Barry Roche leaves Morecambe after 17 years at the Shrimps that spanned both playing and coaching roles.
Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic ...
Roche's Venclexta failure does not affect the oncology pipeline, as HER2 franchise continues to drive revenue growth. Click ...
Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...
Roche and AbbVie have once again come up short in their attempt to gain an additional indication for their blockbuster blood ...
The Swiss drugmaker said it was “encouraged” by the signs of effectiveness of the drug, developed by biotech Prothena, showed ...
Explore more
Roche to advance prasinezumab into phase III development for early-stage Parkinson's disease: Basel Tuesday, June 17, 2025, 09:00 Hrs [IST] Roche announced its decision to proceed ...
Featuring works from Chelsea Odufu, Laurena Finéus, Jarrett Key, and more, the show challenges how we encounter personal ...
AbbVie is deploying more capital into its pipeline, which features 50 programs in mid- and late-stage development and over ...
Other appointments to BIO's board for the 2025 through 2026 term include: Arcutis Bio's Frank Watanabe, named vice-chair; ...
This would mark another shift in Japan’s arms industry, which so far has been largely restricted to producing equipment for ...
11h
Stocktwits on MSNRoche Stock Slides After Failed Blood Cancer Trial With AbbVie, But Parkinson’s Therapy Progress Boosts Retail MoodShares of Roche drew increased retail attention Monday after the Swiss drugmaker said it would move its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results